M. Endoh and M. Hori, Acute heart failure: inotropic agents and their clinical uses, Expert Opin Pharmacother, vol.7, pp.2179-2202, 2006.

M. Endoh, Mechanism of action of Ca2+ sensitizers -update, Cardiovasc Drugs Ther, vol.15, pp.397-403, 2001.

T. Sorsa, P. Pollesello, and R. J. Solaro, The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c, Mol Cell Biochem, vol.266, pp.87-107, 2004.

O. Cazorla, A. Lacampagne, J. Fauconnier, and G. Vassort, SR33805, a Ca2+ antagonist with length-dependent Ca2+ -sensitizing properties in cardiac myocytes, Br J Pharmacol, vol.139, pp.99-108, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01824393

P. Chatelain, P. Dewinkeleer, P. Beaufort, L. Meysmans, and M. Clinet, Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane, Eur J Pharmacol, vol.267, pp.151-160, 1994.

P. Chatelain, M. Clinet, P. Polster, C. B. Manning, and A. S. , In vitro characterization of a novel Ca2+ entry blocker: SR 33805, Eur J Pharmacol, vol.246, pp.181-193, 1993.

S. Ieiri, K. Hirano, J. Nishimura, S. Suita, and H. Kanaide, Alteration of the [Ca(2+)](i)-force relationship during the vasorelaxation induced by a Ca(2+) channel blocker SR33805 in the porcine coronary artery, Br J Pharmacol, vol.131, pp.1597-1606, 2000.

T. Kobayashi and R. J. Solaro, Calcium, thin filaments, and the integrative biology of cardiac contractility, Annu Rev Physiol, vol.67, pp.39-67, 2005.

A. Mou, Y. Reboul, C. Andre, L. Lacampagne, A. Cazorla et al., Late exercise training improves non-uniformity of transmural myocardial function in rats with ischaemic heart failure, Cardiovasc Res, vol.81, pp.555-564, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01824366

O. Cazorla, S. Szilagyi, L. Guennec, J. Y. Vassort, G. Lacampagne et al., Transmural stretchdependent regulation of contractile properties in rat heart and its alteration after myocardial infarction, FASEB J, vol.19, pp.88-90, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01824390

T. Kobayashi, J. L. De-tombe, and P. P. , Cardiac thin filament regulation, Pflugers Arch, vol.457, pp.37-46, 2008.

I. F. Edes, A. Toth, G. Csanyi, M. Lomnicka, S. Chlopicki et al., Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44), J Mol Cell Cardiol, vol.45, pp.363-372, 2008.

H. Zhang, X. Chen, E. Gao, S. M. Macdonnell, W. Wang et al., Increasing cardiac contractility after myocardial infarction exacerbates cardiac injury and pump dysfunction, Circ Res, vol.107, pp.800-809, 2010.

M. Endoh, Cardiac Ca2+ signaling and Ca2+ sensitizers, Circ J, vol.72, pp.1915-1925, 2008.

K. M. Shioura, M. Farjah, D. L. Geenen, R. J. Solaro, and P. H. Goldspink, Myofilament calcium sensitization delays decompensated hypertrophy differently between the sexes following myocardial infarction, Am J Physiol Regul Integr Comp Physiol, vol.300, pp.361-368, 2011.

G. Romey and M. Lazdunski, Effects of a new class of calcium antagonists, SR33557 (fantofarone) and SR33805, on neuronal voltage-activated Ca++ channels, J Pharmacol Exp Ther, vol.271, pp.1348-1352, 1994.

J. Bokenes, J. M. Aronsen, J. A. Birkeland, U. L. Henriksen, W. E. Louch et al., Slow contractions characterize failing rat hearts, Basic Res Cardiol, vol.103, pp.328-344, 2008.

R. Kaprielian, A. D. Wickenden, Z. Kassiri, T. G. Parker, P. P. Liu et al., Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction, J Physiol, vol.517, pp.229-245, 1999.

J. A. Lee and D. G. Allen, EMD 53998 sensitizes the contractile proteins to calcium in intact ferret ventricular muscle, Circ Res, vol.69, pp.927-936, 1991.

J. White, J. A. Lee, N. Shah, and C. H. Orchard, Differential effects of the optical isomers of EMD 53998 on contraction and cytoplasmic Ca2+ in isolated ferret cardiac muscle, Circ Res, vol.73, pp.61-70, 1993.

R. J. Hajjar, U. Schmidt, P. Helm, and J. K. Gwathmey, Ca++ sensitizers impair cardiac relaxation in failing human myocardium, J Pharmacol Exp Ther, vol.280, pp.247-254, 1997.

R. J. Solaro, G. Gambassi, D. M. Warshaw, M. R. Keller, H. A. Spurgeon et al., Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments, Circ Res, vol.73, pp.981-990, 1993.

L. A. Lehtonen, Levosimendan: a parenteral calcium-sensitising drug with additional vasodilatory properties, Expert Opin Investig Drugs, vol.10, pp.955-970, 2001.

S. Masutani, H. J. Cheng, M. Hyttila-hopponen, J. Levijoki, A. Heikkila et al., Orally available levosimendan dose-related positive inotropic and lusitropic effect in conscious chronically instrumented normal and heart failure dogs, J Pharmacol Exp Ther, vol.325, pp.236-247, 2008.

J. Y. Chan, M. Takeda, L. E. Briggs, M. L. Graham, J. T. Lu et al., Identification of cardiac-specific myosin light chain kinase, Circ Res, vol.102, pp.571-580, 2008.

S. Richard, E. Perrier, J. Fauconnier, R. Perrier, L. Pereira et al., Ca(2+)-induced Ca(2+) entry' or how the L-type Ca(2+) channel remodels its own signalling pathway in cardiac cells, Prog Biophys Mol Biol, vol.90, pp.118-135, 2006.

G. M. Arteaga, K. A. Palmiter, J. M. Leiden, and R. J. Solaro, Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I, J Physiol, vol.526, pp.541-549, 2000.

Y. Pi, D. Zhang, K. R. Kemnitz, H. Wang, and J. W. Walker, Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium, J Physiol, vol.552, pp.845-857, 2003.

I. Morano, Tuning the human heart molecular motors by myosin light chains, J Mol Med, vol.77, pp.544-555, 1999.

M. Chandra, W. J. Dong, B. S. Pan, H. C. Cheung, and R. J. Solaro, Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C, Biochemistry, vol.36, pp.13305-13311, 1997.

U. Landmesser, K. C. Wollert, and H. Drexler, Potential novel pharmacological therapies for myocardial remodelling, Cardiovasc Res, vol.81, pp.519-527, 2009.

D. M. Bers, Calcium and cardiac rhythms: physiological and pathophysiological, Circ Res, vol.90, pp.14-17, 2002.

M. Kruger and W. A. Linke, Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension, J Muscle Res Cell Motil, vol.27, pp.435-444, 2006.

M. R. Wolff, S. H. Buck, S. W. Stoker, M. L. Greaser, and R. M. Mentzer, Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation, J Clin Invest, vol.98, pp.167-176, 1996.

N. Hamdani, V. Kooij, S. Van-dijk, D. Merkus, W. J. Paulus et al., Sarcomeric dysfunction in heart failure, Cardiovasc Res, vol.77, pp.649-658, 2008.

K. Brixius, S. Reicke, H. Reuter, and R. H. Schwinger, Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium, Z Kardiol, vol.91, pp.312-318, 2002.

E. Kristof, G. Szigeti, Z. Papp, A. Bodi, N. A. Ball et al., The effects of levosimendan on the left ventricular function and protein phosphorylation in post-ischemic guinea pig hearts, Basic Res Cardiol, vol.94, pp.223-230, 1999.

Y. Ke, L. Wang, W. G. Pyle, P. P. De-tombe, and R. J. Solaro, Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes, Circ Res, vol.94, pp.194-200, 2004.

Y. Ke, A. G. Butt, M. Swart, Y. F. Liu, and F. J. Mcdonald, COMMD1 downregulates the epithelial sodium channel through Nedd4 -2, Am J Physiol Renal Physiol, vol.298, pp.1445-1456, 2010.

A. Kaumann, S. Bartel, P. Molenaar, L. Sanders, K. Burrell et al., Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure, Circulation, vol.99, pp.65-72, 1999.

S. B. Marston and P. P. De-tombe, Troponin phosphorylation and myofilament Ca2+-sensitivity in heart failure: increased or decreased?, J Mol Cell Cardiol, vol.45, pp.603-607, 2008.

N. Hamdani, W. J. Paulus, L. Van-heerebeek, A. Borbely, N. M. Boontje et al., Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction, Eur Heart J, vol.30, pp.1863-1872, 2009.